Visteon (VC) Financials

$110.23 +2.07 (+1.91%)

Closing price 04:00 PM Eastern

Extended Trading

$110.22 -0.01 (-0.01%)

As of 04:35 PM Eastern

Annual Income Statements for Visteon

This table shows Visteon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	2,284	75	176	164	70	-56	41	124	568	296	201
Consolidated Net Income / (Loss)	2,328	91	192	174	81	-48	50	130	587	306	213
Net Income / (Loss) Continuing Operations	42	131	175	173	82	-48	50	130	587	306	213
Total Pre-Tax Income	69	161	223	216	106	-20	81	175	257	298	338
Total Operating Income	211	183	265	189	109	-15	83	166	275	292	322
Total Gross Profit	430	456	491	411	324	245	254	368	487	531	532
Total Revenue	3,245	3,161	3,146	2,984	2,945	2,548	2,773	3,756	3,954	3,866	3,768
Operating Revenue	3,245	3,161	3,146	2,984	2,945	2,548	2,773	3,756	3,954	3,866	3,768
Total Cost of Revenue	2,815	2,705	2,655	2,573	2,621	2,303	2,519	3,388	3,467	3,335	3,236
Operating Cost of Revenue	2,815	2,705	2,655	2,573	2,621	2,303	2,519	3,388	3,467	3,335	3,236
Total Operating Expenses	219	273	226	222	215	260	171	202	212	239	210
Selling, General & Admin Expense	245	224	226	193	221	193	175	188	207	207	202
Restructuring Charge	36	49	14	29	4.00	76	14	14	5.00	32	8.00
Total Other Income / (Expense), net	-142	-22	-42	27	-3.00	-5.00	-2.00	9.00	-18	6.00	16
Interest Expense	24	18	21	14	13	16	10	14	17	15	13
Interest & Investment Income	12	8.00	12	20	10	11	8.00	3.00	0.00	14	30
Other Income / (Expense), net	-130	-12	-33	21	-	-	-	20	-1.00	7.00	-1.00
Income Tax Expense	27	30	48	43	24	28	31	45	-330	-8.00	125
Net Income / (Loss) Attributable to Noncontrolling Interest	44	16	16	10	11	8.00	9.00	6.00	19	10	12
Basic Earnings per Share	$54.00	$2.14	$5.57	$5.56	$2.49	($2.01)	$1.46	$4.41	$20.21	$10.72	$7.39
Weighted Average Basic Shares Outstanding	42.30M	35M	31.60M	29.50M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Diluted Earnings per Share	$52.63	$2.12	$5.47	$5.52	$2.48	($2.01)	$1.44	$4.35	$19.93	$10.61	$7.28
Weighted Average Diluted Shares Outstanding	42.30M	35M	31.60M	29.50M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Weighted Average Basic & Diluted Shares Outstanding	42.30M	35M	31.60M	29.50M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Cash Dividends to Common per Share	$43.40	$43.40	-	-	-	-	-	-	-	-	$0.38

This table shows Visteon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	66	366	42	71	39	122	67	65	57	14	31
Consolidated Net Income / (Loss)	71	373	44	75	40	125	69	69	59	18	33
Net Income / (Loss) Continuing Operations	71	373	44	75	40	125	69	69	59	18	33
Total Pre-Tax Income	92	77	63	100	51	84	95	97	81	65	49
Total Operating Income	91	76	65	97	52	78	91	92	75	64	41
Total Gross Profit	143	130	119	147	131	134	138	141	131	122	113
Total Revenue	1,014	990	933	1,014	980	939	934	969	917	948	954
Operating Revenue	1,014	990	933	1,014	980	939	934	969	917	948	954
Total Cost of Revenue	871	860	814	867	849	805	796	828	786	826	841
Operating Cost of Revenue	871	860	814	867	849	805	796	828	786	826	841
Total Operating Expenses	52	54	54	50	79	56	47	49	56	58	72
Selling, General & Admin Expense	52	51	52	49	51	55	47	48	53	54	54
Restructuring Charge	0.00	3.00	2.00	1.00	28	1.00	0.00	1.00	3.00	4.00	18
Total Other Income / (Expense), net	1.00	1.00	-2.00	3.00	-1.00	6.00	4.00	5.00	6.00	1.00	8.00
Interest Expense	4.00	4.00	4.00	4.00	4.00	3.00	3.00	4.00	3.00	3.00	3.00
Interest & Investment Income	2.00	2.00	0.00	4.00	1.00	9.00	6.00	8.00	7.00	9.00	7.00
Other Income / (Expense), net	3.00	3.00	2.00	3.00	2.00	-	1.00	1.00	2.00	-5.00	4.00
Income Tax Expense	21	-296	19	25	11	-41	26	28	22	47	16
Net Income / (Loss) Attributable to Noncontrolling Interest	5.00	7.00	2.00	4.00	1.00	3.00	2.00	4.00	2.00	4.00	2.00
Basic Earnings per Share	$2.35	$13.03	$1.52	$2.57	$1.41	$4.43	$2.46	$2.38	$2.09	$0.53	$1.16
Weighted Average Basic Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M
Diluted Earnings per Share	$2.32	$12.85	$1.50	$2.54	$1.40	$4.38	$2.44	$2.36	$2.04	$0.52	$1.14
Weighted Average Diluted Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M
Weighted Average Basic & Diluted Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M

This table details how cash moves in and out of Visteon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	1,902	-1,855	-173	-242	2.00	31	-45	68	-5.00	108	147
Net Cash From Operating Activities	338	116	215	204	183	168	58	167	267	427	410
Net Cash From Continuing Operating Activities	338	116	215	204	183	168	58	167	267	427	410
Net Income / (Loss) Continuing Operations	2,328	91	192	174	81	-48	50	130	587	306	213
Consolidated Net Income / (Loss)	2,328	91	192	174	81	-48	50	130	587	306	213
Depreciation Expense	169	84	87	91	100	104	108	108	104	96	109
Non-Cash Adjustments To Reconcile Net Income	-2,245	55	28	-10	19	20	53	34	43	58	49
Changes in Operating Assets and Liabilities, net	86	-114	-92	-51	-17	92	-153	-105	-467	-33	39
Net Cash From Investing Activities	2,358	302	-173	-98	-128	-98	-63	-68	-123	-189	-181
Net Cash From Continuing Investing Activities	2,358	302	-173	-98	-128	-98	-63	-68	-123	-189	-181
Purchase of Property, Plant & Equipment	-187	-75	-99	-127	-142	-104	-70	-81	-125	-137	-133
Acquisitions	-4.00	-25	-95	16	-3.00	-2.00	-5.00	0.00	0.00	-55	-50
Purchase of Investments	-47	47	-	-	-	-	-	0.00	0.00	-5.00	0.00
Other Investing Activities, net	-3.00	-18	6.00	13	11	0.00	8.00	1.00	2.00	8.00	2.00
Net Cash From Financing Activities	-774	-2,262	-234	-335	-49	-58	-29	-9.00	-156	-100	-116
Net Cash From Continuing Financing Activities	-774	-2,262	-234	-335	-49	-58	-29	-9.00	-156	-100	-116
Repayment of Debt	-249	-2.00	6.00	14	-20	-435	6.00	-357	-13	-18	-18
Repurchase of Common Equity	-500	-500	-200	-300	-20	-16	0.00	0.00	-106	-63	-57
Payment of Dividends	-55	-1,749	-39	-42	-9.00	-7.00	-35	-2.00	-29	-12	-36
Other Financing Activities, net	30	-11	-1.00	-7.00	-	-	0.00	0.00	-8.00	-7.00	-5.00
Effect of Exchange Rate Changes	-20	-11	19	-13	-4.00	19	-11	-22	7.00	-30	34
Cash Interest Paid	24	14	16	15	14	18	15	14	16	14	12
Cash Income Taxes Paid	67	92	49	47	40	19	15	29	68	73	98

This table details how cash moves in and out of Visteon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	26	33	-7.00	1.00	45	73	32	-20	127	8.00	-91
Net Cash From Operating Activities	127	98	69	57	98	203	70	95	127	118	6.00
Net Cash From Continuing Operating Activities	127	98	61	57	98	203	70	95	127	118	6.00
Net Income / (Loss) Continuing Operations	71	373	44	75	40	125	69	69	59	18	33
Consolidated Net Income / (Loss)	71	373	44	75	40	125	69	69	59	18	33
Depreciation Expense	24	25	22	24	25	25	25	27	28	29	29
Non-Cash Adjustments To Reconcile Net Income	10	9.00	11	11	13	20	9.00	10	10	20	10
Changes in Operating Assets and Liabilities, net	22	-309	-16	-53	20	33	-33	-11	30	51	-66
Net Cash From Investing Activities	-31	-43	-37	-35	-76	-41	-33	-82	-21	-45	-48
Net Cash From Continuing Investing Activities	-31	-43	-37	-35	-76	-41	-35	-82	-21	-45	-48
Purchase of Property, Plant & Equipment	-31	-43	-	-31	-28	-41	-35	-	-	-45	-36
Purchase of Investments	-	-	-	-	-	-	1.00	-	-	-	-12
Other Investing Activities, net	1.00	-1.00	-37	1.00	1.00	6.00	-1.00	-67	67	-	0.00
Net Cash From Financing Activities	-62	-37	-31	-5.00	-4.00	-60	-18	-20	-14	-64	-47
Net Cash From Continuing Financing Activities	-62	-37	-31	-5.00	-4.00	-60	-18	-20	-14	-64	-47
Repayment of Debt	-7.00	-5.00	-	-5.00	-4.00	-5.00	-4.00	-	-	-5.00	-4.00
Repurchase of Common Equity	-46	-30	-20	-	-	-43	-7.00	-	-	-50	-30
Payment of Dividends	-12	-2.00	0.00	-	-	-12	-4.00	-14	-10	-8.00	-10
Other Financing Activities, net	3.00	-	-11	-	-	-	-3.00	-10	9.00	-1.00	-3.00
Effect of Exchange Rate Changes	-8.00	15	-	-16	27	-29	13	-	-	-1.00	-2.00

This table presents Visteon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	4,681	2,373	2,304	2,007	2,271	2,271	2,234	2,450	2,727	2,966	3,386
Total Current Assets	4,053	1,708	1,603	1,296	1,345	1,341	1,424	1,710	1,616	1,596	1,785
Cash & Equivalents	2,728	878	706	463	466	496	452	520	515	623	771
Restricted Cash	8.00	4.00	3.00	4.00	3.00	4.00	3.00	3.00	3.00	3.00	2.00
Accounts Receivable	502	505	530	486	514	484	549	672	666	578	613
Inventories, net	187	151	189	184	169	177	262	348	298	283	269
Other Current Assets	581	170	175	159	193	180	158	167	134	109	130
Plant, Property, & Equipment, net	351	345	377	397	0.00	0.00	0.00	0.00	0.00	0.00	524
Total Noncurrent Assets	277	320	324	314	926	930	810	740	1,111	1,370	1,077
Long-Term Investments	56	45	41	42	48	60	54	49	35	27	29
Goodwill	133	129	132	129	127	127	118	99	90	152	222
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	42	384	545	511
Other Noncurrent Operating Assets	88	146	151	143	751	743	638	550	602	646	315
Total Liabilities & Shareholders' Equity	4,681	2,373	2,304	2,007	2,271	2,271	2,234	2,450	2,727	2,966	3,386
Total Liabilities	3,482	1,649	1,543	1,425	1,676	1,761	1,618	1,676	1,604	1,552	1,735
Total Current Liabilities	2,772	911	801	721	798	824	852	1,035	931	916	992
Short-Term Debt	37	36	46	57	37	0.00	4.00	13	18	18	18
Accounts Payable	482	463	470	436	511	500	522	657	551	505	540
Current Employee Benefit Liabilities	132	103	105	67	73	83	80	90	99	107	122
Other Current Liabilities	370	309	180	161	177	241	246	275	263	286	312
Total Noncurrent Liabilities	710	738	742	704	878	937	766	641	673	636	743
Long-Term Debt	346	346	347	348	348	349	349	336	318	301	283
Capital Lease Obligations	-	-	-	0.00	139	146	-	-	79	78	109
Noncurrent Deferred & Payable Income Tax Liabilities	21	20	23	23	27	28	27	27	31	43	51
Noncurrent Employee Benefit Liabilities	268	303	277	257	292	322	198	115	160	127	88
Other Noncurrent Operating Liabilities	75	69	95	76	72	92	192	163	85	87	212
Total Equity & Noncontrolling Interests	1,199	724	761	582	595	510	616	774	1,123	1,414	1,651
Total Preferred & Common Equity	1,057	586	637	465	480	387	516	675	1,038	1,333	1,568
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,057	586	637	465	480	387	516	675	1,038	1,333	1,568
Common Stock	1,346	1,328	1,340	1,336	1,343	1,349	1,350	1,353	1,357	1,377	1,399
Retained Earnings	1,194	1,269	1,445	1,609	1,679	1,623	1,664	1,788	2,274	2,652	2,838
Treasury Stock	-1,293	-1,778	-1,974	-2,264	-2,275	-2,281	-2,269	-2,253	-2,339	-2,390	-2,429
Accumulated Other Comprehensive Income / (Loss)	-190	-233	-174	-216	-267	-304	-229	-213	-254	-306	-240
Noncontrolling Interest	142	138	124	117	115	123	100	99	85	81	83

This table presents Visteon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	2,326	2,405	2,321	2,357	2,739	2,731	2,893	2,997	3,192	3,254	3,423
Total Current Assets	1,594	1,664	1,597	1,622	1,630	1,641	1,702	1,697	1,723	1,778	1,821
Cash & Equivalents	362	484	455	481	504	505	550	655	668	762	680
Restricted Cash	3.00	3.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	3.00	2.00
Accounts Receivable	733	695	678	679	652	695	719	613	621	574	675
Inventories, net	341	358	329	318	342	311	321	310	296	313	316
Other Current Assets	155	124	131	140	129	127	109	116	135	126	148
Plant, Property, & Equipment, net	336	365	367	377	415	416	438	462	485	489	516
Total Noncurrent Assets	396	376	357	358	694	674	753	838	984	987	1,086
Long-Term Investments	51	44	37	36	30	25	27	29	25	27	31
Goodwill	101	95	88	83	87	84	157	153	224	224	216
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	378	371	387	439	444	441	513
Other Noncurrent Operating Assets	244	237	232	239	199	194	182	217	291	295	326
Total Liabilities & Shareholders' Equity	2,326	2,405	2,321	2,357	2,739	2,731	2,893	2,997	3,192	3,254	3,423
Total Liabilities	1,677	1,598	1,543	1,556	1,605	1,533	1,620	1,600	1,694	1,692	1,781
Total Current Liabilities	980	964	911	948	938	887	937	927	921	941	1,053
Short-Term Debt	9.00	21	21	18	18	18	18	18	18	18	18
Accounts Payable	645	605	564	595	566	529	547	556	557	533	613
Current Employee Benefit Liabilities	79	77	74	86	84	81	98	90	88	111	98
Other Current Liabilities	247	261	252	249	270	259	274	263	258	279	324
Total Noncurrent Liabilities	697	634	632	608	667	646	683	673	773	751	728
Long-Term Debt	340	331	327	323	314	309	306	297	292	288	279
Capital Lease Obligations	97	99	93	87	89	83	79	112	111	115	115
Noncurrent Deferred & Payable Income Tax Liabilities	26	28	30	30	32	34	46	47	62	62	52
Noncurrent Employee Benefit Liabilities	171	112	109	104	156	149	143	125	115	105	83
Other Noncurrent Operating Liabilities	63	64	73	64	76	71	109	92	193	181	199
Total Equity & Noncontrolling Interests	649	807	778	801	1,134	1,198	1,273	1,397	1,498	1,562	1,642
Total Preferred & Common Equity	555	720	705	724	1,049	1,113	1,185	1,313	1,422	1,483	1,556
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	555	720	705	724	1,049	1,113	1,185	1,313	1,422	1,483	1,556
Common Stock	1,352	1,335	1,342	1,350	1,351	1,361	1,370	1,369	1,379	1,390	1,390
Retained Earnings	1,754	1,822	1,842	1,908	2,316	2,387	2,426	2,613	2,678	2,727	2,859
Treasury Stock	-2,257	-2,240	-2,266	-2,309	-2,350	-2,349	-2,348	-2,382	-2,380	-2,379	-2,441
Accumulated Other Comprehensive Income / (Loss)	-294	-197	-213	-225	-268	-286	-263	-287	-255	-255	-252
Noncontrolling Interest	94	87	73	77	85	85	88	84	76	79	86

This table displays calculated financial ratios and metrics derived from Visteon's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	25.48%	-2.59%	-0.47%	-5.15%	-1.31%	-13.48%	8.83%	35.45%	5.27%	-2.23%	-2.53%
EBITDA Growth	-7.06%	2.00%	25.10%	-5.64%	-30.56%	-57.42%	114.61%	53.93%	28.57%	4.50%	8.86%
EBIT Growth	8,200.00%	111.11%	35.67%	-9.48%	-48.10%	-113.76%	653.33%	124.10%	47.31%	9.12%	7.36%
NOPAT Growth	18,447.83%	15.93%	39.66%	-27.21%	-44.30%	-112.45%	587.95%	140.69%	338.21%	-48.50%	-32.32%
Net Income Growth	1,230.10%	-96.09%	110.99%	-9.38%	-53.45%	-159.26%	204.17%	160.00%	288.46%	-43.76%	-30.39%
EPS Growth	917.24%	-95.97%	158.02%	0.91%	-55.07%	-181.05%	171.64%	202.08%	291.95%	-42.40%	-31.39%
Operating Cash Flow Growth	19.01%	-65.68%	85.34%	-5.12%	-10.29%	-8.20%	-65.48%	187.93%	59.88%	59.93%	-3.98%
Free Cash Flow Firm Growth	-112.08%	358.35%	-103.67%	554.07%	-151.28%	469.21%	-75.27%	-10.82%	229.17%	96.75%	-19.65%
Invested Capital Growth	165.59%	-63.77%	125.70%	18.32%	25.94%	-26.08%	3.37%	19.78%	78.77%	7.01%	8.72%
Revenue Q/Q Growth	61.60%	0.22%	-0.60%	-2.16%	0.44%	1.72%	-0.04%	7.99%	-1.84%	-1.30%	0.24%
EBITDA Q/Q Growth	-18.30%	87.50%	1.27%	2.03%	3.98%	-16.04%	9.14%	8.89%	4.13%	-0.25%	-3.37%
EBIT Q/Q Growth	-13.83%	228.85%	0.43%	3.45%	5.83%	-400.00%	29.69%	12.73%	7.45%	-0.33%	-5.59%
NOPAT Q/Q Growth	3,428.43%	-18.33%	15.53%	-9.28%	9.36%	-400.00%	46.38%	-5.14%	197.13%	-47.51%	-32.63%
Net Income Q/Q Growth	6.30%	-16.51%	14.29%	9.43%	-6.90%	-65.52%	42.86%	0.00%	202.40%	-46.62%	-33.44%
EPS Q/Q Growth	9.74%	-43.32%	15.64%	15.24%	-10.47%	-41.55%	44.00%	2.35%	216.33%	-46.31%	-34.65%
Operating Cash Flow Q/Q Growth	-10.58%	13.73%	3.86%	5.70%	-14.88%	3.70%	-1.69%	131.94%	-20.06%	32.61%	-17.17%
Free Cash Flow Firm Q/Q Growth	-110.35%	182.31%	-117.94%	199.18%	20.47%	31.39%	64.70%	219.68%	-30.41%	47.20%	-50.57%
Invested Capital Q/Q Growth	100.81%	-32.20%	15.76%	-2.45%	-2.43%	-12.57%	-11.88%	-18.85%	39.12%	-3.83%	5.71%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	13.25%	14.43%	15.61%	13.77%	11.00%	9.62%	9.16%	9.80%	12.32%	13.74%	14.12%
EBITDA Margin	7.70%	8.07%	10.14%	10.09%	7.10%	3.49%	6.89%	7.83%	9.56%	10.22%	11.41%
Operating Margin	6.50%	5.79%	8.42%	6.33%	3.70%	-0.59%	2.99%	4.42%	6.96%	7.55%	8.55%
EBIT Margin	2.50%	5.41%	7.37%	7.04%	3.70%	-0.59%	2.99%	4.95%	6.93%	7.73%	8.52%
Profit (Net Income) Margin	71.74%	2.88%	6.10%	5.83%	2.75%	-1.88%	1.80%	3.46%	12.77%	7.35%	5.65%
Tax Burden Percent	3,373.91%	56.52%	86.10%	80.56%	76.42%	240.00%	61.73%	74.29%	196.50%	95.30%	63.02%
Interest Burden Percent	85.19%	94.15%	96.12%	102.86%	97.25%	133.33%	97.59%	94.09%	93.80%	99.67%	105.30%
Effective Tax Rate	39.13%	18.63%	21.52%	19.91%	22.64%	0.00%	38.27%	25.71%	-96.50%	4.70%	36.98%
Return on Invested Capital (ROIC)	37.77%	44.25%	71.34%	34.33%	15.62%	-2.01%	11.32%	24.39%	70.36%	27.30%	16.79%
ROIC Less NNEP Spread (ROIC-NNEP)	-150.22%	53.51%	74.88%	24.51%	22.46%	127.30%	12.44%	20.87%	89.96%	24.39%	13.68%
Return on Net Nonoperating Assets (RNNOA)	116.40%	-34.79%	-45.48%	-8.41%	-1.85%	-6.68%	-2.44%	-5.69%	-17.12%	-3.95%	-2.89%
Return on Equity (ROE)	154.17%	9.46%	25.86%	25.91%	13.76%	-8.69%	8.88%	18.71%	53.24%	23.35%	13.90%
Cash Return on Invested Capital (CROIC)	-52.81%	137.86%	-5.85%	17.55%	-7.35%	27.98%	8.01%	6.39%	13.85%	20.53%	8.43%
Operating Return on Assets (OROA)	1.62%	4.85%	9.92%	9.74%	5.10%	-0.66%	3.68%	7.94%	10.59%	10.70%	10.11%
Return on Assets (ROA)	46.54%	2.58%	8.21%	8.07%	3.79%	-2.11%	2.22%	5.55%	19.51%	10.16%	6.71%
Return on Common Equity (ROCE)	98.12%	8.09%	21.30%	21.26%	11.05%	-6.82%	7.12%	16.03%	48.08%	21.75%	13.16%
Return on Equity Simple (ROE_SIMPLE)	220.25%	15.53%	30.14%	37.42%	16.88%	-12.40%	9.69%	19.26%	48.65%	23.11%	0.00%
Net Operating Profit after Tax (NOPAT)	128	149	208	151	84	-11	51	123	540	278	203
NOPAT Margin	3.96%	4.71%	6.61%	5.07%	2.86%	-0.41%	1.85%	3.28%	13.67%	7.20%	5.39%
Net Nonoperating Expense Percent (NNEP)	188.00%	-9.26%	-3.54%	9.82%	-6.85%	-129.31%	-1.12%	3.53%	-19.60%	2.90%	3.11%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	10.98%	35.13%	16.30%	9.85%
Cost of Revenue to Revenue	86.75%	85.57%	84.39%	86.23%	89.00%	90.38%	90.84%	90.20%	87.68%	86.26%	85.88%
SG&A Expenses to Revenue	7.55%	7.09%	7.18%	6.47%	7.50%	7.57%	6.31%	5.01%	5.24%	5.35%	5.36%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.75%	8.64%	7.18%	7.44%	7.30%	10.20%	6.17%	5.38%	5.36%	6.18%	5.57%
Earnings before Interest and Taxes (EBIT)	81	171	232	210	109	-15	83	186	274	299	321
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	250	255	319	301	209	89	191	294	378	395	430
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.56	4.66	6.11	3.75	5.04	9.03	6.03	5.45	3.35	1.99	1.65
Price to Tangible Book Value (P/TBV)	2.93	5.98	7.71	5.19	6.86	13.44	7.82	6.39	3.66	2.28	1.93
Price to Revenue (P/Rev)	0.83	0.86	1.24	0.58	0.82	1.37	1.12	0.98	0.88	0.63	0.69
Price to Earnings (P/E)	1.19	36.43	22.11	10.63	34.59	0.00	75.89	29.69	7.15	8.94	12.91
Dividend Yield	0.00%	54.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%
Earnings Yield	84.36%	2.74%	4.52%	9.41%	2.89%	0.00%	1.32%	3.37%	13.99%	11.18%	7.75%
Enterprise Value to Invested Capital (EV/IC)	0.80	12.99	9.06	3.67	4.23	7.98	6.64	6.46	3.47	2.16	1.82
Enterprise Value to Revenue (EV/Rev)	0.12	0.74	1.16	0.59	0.86	1.39	1.10	0.95	0.87	0.59	0.61
Enterprise Value to EBITDA (EV/EBITDA)	1.57	9.12	11.47	5.83	12.17	39.91	16.00	12.10	9.05	5.76	5.32
Enterprise Value to EBIT (EV/EBIT)	4.86	13.60	15.77	8.36	23.34	0.00	36.81	19.13	12.48	7.61	7.12
Enterprise Value to NOPAT (EV/NOPAT)	3.06	15.62	17.59	11.60	30.16	0.00	59.64	28.85	6.33	8.18	11.27
Enterprise Value to Operating Cash Flow (EV/OCF)	1.16	20.05	17.02	8.61	13.90	21.14	52.68	21.30	12.81	5.33	5.58
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	5.01	0.00	22.69	0.00	24.24	84.33	110.10	32.16	10.87	22.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.32	0.53	0.52	0.70	0.88	0.97	0.57	0.45	0.37	0.30	0.25
Long-Term Debt to Equity	0.29	0.48	0.46	0.60	0.82	0.97	0.57	0.43	0.35	0.29	0.24
Financial Leverage	-0.77	-0.65	-0.61	-0.34	-0.08	-0.05	-0.20	-0.27	-0.19	-0.16	-0.21
Leverage Ratio	3.31	3.67	3.15	3.21	3.63	4.11	4.00	3.37	2.73	2.30	2.07
Compound Leverage Factor	2.82	3.45	3.03	3.30	3.53	5.48	3.90	3.17	2.56	2.29	2.18
Debt to Total Capital	24.21%	34.54%	34.06%	41.03%	46.83%	49.25%	36.43%	31.08%	26.98%	23.26%	19.89%
Short-Term Debt to Total Capital	2.34%	3.26%	3.99%	5.78%	3.31%	0.00%	0.41%	1.16%	1.17%	1.05%	0.87%
Long-Term Debt to Total Capital	21.87%	31.28%	30.07%	35.26%	43.52%	49.25%	36.02%	29.92%	25.81%	22.20%	19.02%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	8.98%	12.48%	10.75%	11.85%	10.28%	12.24%	10.32%	8.82%	5.53%	4.75%	4.03%
Common Equity to Total Capital	66.81%	52.98%	55.20%	47.11%	42.90%	38.51%	53.25%	60.11%	67.49%	72.00%	76.08%
Debt to EBITDA	1.53	1.50	1.23	1.35	2.51	5.56	1.85	1.19	1.10	1.01	0.95
Net Debt to EBITDA	-9.82	-2.14	-1.12	-0.35	0.03	-0.73	-0.82	-0.76	-0.37	-0.65	-0.91
Long-Term Debt to EBITDA	1.38	1.36	1.09	1.16	2.33	5.56	1.83	1.14	1.05	0.96	0.91
Debt to NOPAT	2.98	2.57	1.89	2.68	6.21	-47.14	6.89	2.83	0.77	1.43	2.02
Net Debt to NOPAT	-19.12	-3.66	-1.72	-0.69	0.08	6.19	-3.04	-1.81	-0.26	-0.92	-1.93
Long-Term Debt to NOPAT	2.69	2.32	1.67	2.30	5.78	-47.14	6.81	2.72	0.73	1.36	1.93
Altman Z-Score	1.90	3.72	4.51	4.03	3.65	3.56	3.87	4.45	4.55	4.17	3.78
Noncontrolling Interest Sharing Ratio	36.36%	14.56%	17.64%	17.94%	19.71%	21.54%	19.80%	14.32%	9.70%	6.82%	5.35%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.46	1.87	2.00	1.80	1.69	1.63	1.67	1.65	1.74	1.74	1.80
Quick Ratio	1.18	1.52	1.54	1.32	1.23	1.19	1.17	1.15	1.27	1.31	1.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-180	464	-17	77	-40	147	36	32	106	209	102
Operating Cash Flow to CapEx	180.75%	154.67%	217.17%	160.63%	128.87%	161.54%	82.86%	206.17%	213.60%	311.68%	308.27%
Free Cash Flow to Firm to Interest Expense	-7.48	25.77	-0.81	5.53	-3.05	9.16	3.62	2.31	6.26	13.95	7.84
Operating Cash Flow to Interest Expense	14.08	6.44	10.24	14.57	14.08	10.50	5.80	11.93	15.71	28.47	31.54
Operating Cash Flow Less CapEx to Interest Expense	6.29	2.28	5.52	5.50	3.15	4.00	-1.20	6.14	8.35	19.33	21.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.90	1.35	1.38	1.38	1.12	1.23	1.60	1.53	1.38	1.19
Accounts Receivable Turnover	6.28	6.28	6.08	5.87	5.89	5.11	5.37	6.15	5.91	6.22	6.33
Inventory Turnover	14.25	16.01	15.62	13.80	14.85	13.31	11.48	11.11	10.73	11.48	11.72
Fixed Asset Turnover	9.09	9.08	8.71	7.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	5.82	5.72	5.69	5.68	5.54	4.56	4.93	5.75	5.74	6.32	6.19
Days Sales Outstanding (DSO)	58.10	58.14	60.04	62.14	61.97	71.48	67.99	59.33	61.76	58.72	57.69
Days Inventory Outstanding (DIO)	25.61	22.80	23.37	26.46	24.58	27.42	31.81	32.86	34.00	31.79	31.13
Days Payable Outstanding (DPO)	62.69	63.76	64.13	64.26	65.94	80.12	74.04	63.51	63.59	57.79	58.93
Cash Conversion Cycle (CCC)	21.01	17.19	19.28	24.33	20.61	18.78	25.75	28.68	32.17	32.73	29.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	494	179	404	478	602	445	460	551	985	1,054	1,259
Invested Capital Turnover	9.54	9.39	10.79	6.77	5.45	4.87	6.13	7.43	5.15	3.79	3.12
Increase / (Decrease) in Invested Capital	308	-315	225	74	124	-157	15	91	434	69	101
Enterprise Value (EV)	394	2,326	3,659	1,756	2,544	3,552	3,056	3,558	3,421	2,275	2,286
Market Capitalization	2,708	2,733	3,892	1,743	2,422	3,494	3,112	3,682	3,474	2,450	2,595
Book Value per Share	$25.89	$17.23	$20.48	$16.08	$17.16	$13.90	$18.43	$23.98	$37.32	$44.50	$58.47
Tangible Book Value per Share	$22.63	$13.44	$16.24	$11.62	$12.62	$9.34	$14.22	$20.47	$34.09	$39.00	$50.19
Total Capital	1,582	1,106	1,154	987	1,119	1,005	969	1,123	1,538	1,707	2,061
Total Debt	383	382	393	405	524	495	353	349	415	397	410
Total Long-Term Debt	346	346	347	348	487	495	349	336	397	379	392
Net Debt	-2,456	-545	-357	-104	7.00	-65	-156	-223	-138	-256	-392
Capital Expenditures (CapEx)	187	75	99	127	142	104	70	81	125	137	133
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1,465	-49	139	165	115	17	121	165	185	72	38
Debt-free Net Working Capital (DFNWC)	1,318	833	848	632	584	517	576	688	703	698	811
Net Working Capital (NWC)	1,281	797	802	575	547	517	572	675	685	680	793
Net Nonoperating Expense (NNE)	-2,200	58	16	-23	3.32	38	1.23	-6.69	35	-5.72	-10
Net Nonoperating Obligations (NNO)	-705	-545	-357	-104	7.00	-65	-156	-223	-138	-256	-392
Total Depreciation and Amortization (D&A)	169	84	87	91	100	104	108	108	104	96	109
Debt-free, Cash-free Net Working Capital to Revenue	-45.15%	-1.55%	4.42%	5.53%	3.90%	0.67%	4.36%	4.39%	4.68%	1.86%	1.01%
Debt-free Net Working Capital to Revenue	40.62%	26.35%	26.95%	21.18%	19.83%	20.29%	20.77%	18.32%	17.78%	18.05%	21.52%
Net Working Capital to Revenue	39.48%	25.21%	25.49%	19.27%	18.57%	20.29%	20.63%	17.97%	17.32%	17.59%	21.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$54.00	$2.14	$5.57	$5.56	$2.49	($2.01)	$1.46	$4.41	$17.30	$9.93	$7.39
Adjusted Weighted Average Basic Shares Outstanding	38.86M	32.81M	30.92M	28.24M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Adjusted Diluted Earnings per Share	$52.63	$2.12	$5.47	$5.52	$2.48	($2.01)	$1.44	$4.35	$17.05	$9.82	$7.28
Adjusted Weighted Average Diluted Shares Outstanding	38.86M	32.81M	30.92M	28.24M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	38.86M	32.81M	30.92M	28.24M	28.02M	27.92M	28.00M	28.19M	27.49M	27.08M	26.82M
Normalized Net Operating Profit after Tax (NOPAT)	113	189	219	175	87	43	60	134	196	309	208
Normalized NOPAT Margin	3.47%	5.97%	6.96%	5.85%	2.97%	1.68%	2.16%	3.56%	4.96%	7.99%	5.52%
Pre Tax Income Margin	2.13%	5.09%	7.09%	7.24%	3.60%	-0.78%	2.92%	4.66%	6.50%	7.71%	8.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.38	9.50	11.05	15.00	8.38	-0.94	8.30	13.29	16.12	19.93	24.69
NOPAT to Interest Expense	5.35	8.27	9.90	10.81	6.49	-0.66	5.12	8.81	31.79	18.55	15.61
EBIT Less CapEx to Interest Expense	-4.42	5.33	6.33	5.93	-2.54	-7.44	1.30	7.50	8.76	10.80	14.46
NOPAT Less CapEx to Interest Expense	-2.44	4.11	5.19	1.74	-4.44	-7.16	-1.88	3.02	24.43	9.42	5.38
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	2.36%	1,921.98%	20.31%	24.14%	11.11%	-14.58%	70.00%	1.54%	5.74%	4.23%	16.90%
Augmented Payout Ratio	23.84%	2,471.43%	124.48%	196.55%	35.80%	-47.92%	70.00%	1.54%	26.73%	26.41%	43.66%

This table displays calculated financial ratios and metrics derived from Visteon's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	26,819,486.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	26,819,486.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.16
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-1.17%	-6.95%	-3.52%	3.15%	-3.35%	-5.15%	0.11%	-4.44%	-6.43%	0.96%	2.14%
EBITDA Growth	34.09%	16.85%	0.00%	85.07%	-33.05%	-0.96%	31.46%	-3.23%	32.91%	-14.56%	-36.75%
EBIT Growth	54.10%	31.67%	11.67%	143.90%	-42.55%	-1.27%	37.31%	-7.00%	42.59%	-24.36%	-51.09%
NOPAT Growth	48.44%	915.60%	8.99%	123.27%	-41.93%	-68.47%	41.37%	-10.04%	33.95%	-87.02%	-58.22%
Net Income Growth	44.90%	965.71%	15.79%	226.09%	-43.66%	-66.49%	52.27%	-8.00%	47.50%	-87.76%	-52.17%
EPS Growth	50.65%	979.83%	27.12%	262.86%	-39.66%	-65.91%	57.33%	-7.09%	45.71%	-89.94%	-53.28%
Operating Cash Flow Growth	71.62%	-40.61%	463.16%	-6.56%	-22.83%	107.14%	1.45%	66.67%	29.59%	-41.87%	-91.43%
Free Cash Flow Firm Growth	137.59%	-20.26%	-429.93%	-5,101.49%	-942.18%	171.49%	77.68%	70.44%	88.37%	-128.16%	-233.40%
Invested Capital Growth	4.27%	78.77%	40.03%	48.69%	54.80%	7.01%	11.69%	13.77%	8.67%	8.72%	17.94%
Revenue Q/Q Growth	3.15%	-2.37%	-5.76%	8.68%	-3.35%	-4.18%	-0.53%	3.75%	-5.37%	3.38%	0.63%
EBITDA Q/Q Growth	76.12%	-11.86%	-14.42%	39.33%	-36.29%	30.38%	13.59%	2.56%	-12.50%	-16.19%	-15.91%
EBIT Q/Q Growth	129.27%	-15.96%	-15.19%	49.25%	-46.00%	44.44%	17.95%	1.09%	-17.20%	-23.38%	-23.73%
NOPAT Q/Q Growth	115.53%	424.23%	-87.67%	60.25%	-43.94%	184.60%	-44.71%	1.97%	-16.52%	-67.56%	55.80%
Net Income Q/Q Growth	208.70%	425.35%	-88.20%	70.45%	-46.67%	212.50%	-46.40%	2.99%	-14.49%	-69.49%	83.33%
EPS Q/Q Growth	231.43%	453.88%	-88.33%	69.33%	-44.88%	212.86%	-46.12%	0.00%	-13.56%	-74.51%	119.23%
Operating Cash Flow Q/Q Growth	108.20%	-22.83%	-29.59%	-17.39%	71.93%	107.14%	-65.52%	35.71%	33.68%	-7.09%	-94.92%
Free Cash Flow Firm Q/Q Growth	638.42%	-259.71%	-273.01%	-13.70%	-24.34%	113.56%	-216.46%	-50.59%	51.10%	-106.28%	-111.81%
Invested Capital Q/Q Growth	-2.07%	39.12%	3.35%	5.60%	1.95%	-3.83%	7.87%	7.56%	-2.62%	5.71%	6.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.10%	13.13%	12.75%	14.50%	13.37%	14.27%	14.78%	14.55%	14.29%	12.87%	11.84%
EBITDA Margin	11.64%	10.51%	9.54%	12.23%	8.06%	10.97%	12.53%	12.38%	11.45%	9.28%	7.76%
Operating Margin	8.97%	7.68%	6.97%	9.57%	5.31%	8.31%	9.74%	9.49%	8.18%	6.75%	4.30%
EBIT Margin	9.27%	7.98%	7.18%	9.86%	5.51%	8.31%	9.85%	9.60%	8.40%	6.22%	4.72%
Profit (Net Income) Margin	7.00%	37.68%	4.72%	7.40%	4.08%	13.31%	7.17%	7.12%	6.43%	1.90%	3.46%
Tax Burden Percent	77.17%	484.42%	69.84%	75.00%	78.43%	148.81%	70.53%	71.13%	72.84%	27.69%	67.35%
Interest Burden Percent	97.87%	97.47%	94.03%	100.00%	94.44%	107.69%	103.26%	104.30%	105.19%	110.17%	108.89%
Effective Tax Rate	22.83%	-384.42%	30.16%	25.00%	21.57%	-48.81%	29.47%	28.87%	27.16%	72.31%	32.65%
Return on Invested Capital (ROIC)	40.23%	191.46%	21.86%	31.53%	18.07%	46.87%	24.66%	22.47%	19.58%	5.83%	8.85%
ROIC Less NNEP Spread (ROIC-NNEP)	37.78%	188.77%	23.29%	29.00%	18.65%	42.34%	23.16%	20.68%	17.99%	5.74%	6.93%
Return on Net Nonoperating Assets (RNNOA)	-1.64%	-35.92%	-2.35%	-2.61%	-2.43%	-6.86%	-3.44%	-3.05%	-3.48%	-1.21%	-1.28%
Return on Equity (ROE)	38.59%	155.53%	19.51%	28.92%	15.64%	40.02%	21.22%	19.41%	16.11%	4.61%	7.57%
Cash Return on Invested Capital (CROIC)	22.04%	13.85%	28.49%	22.90%	15.76%	20.53%	16.41%	12.19%	18.03%	8.43%	-3.16%
Operating Return on Assets (OROA)	15.95%	12.19%	10.94%	15.43%	8.22%	11.49%	13.28%	12.39%	10.27%	7.38%	5.57%
Return on Assets (ROA)	12.05%	57.55%	7.19%	11.57%	6.09%	18.42%	9.67%	9.19%	7.87%	2.25%	4.08%
Return on Common Equity (ROCE)	34.04%	140.45%	17.78%	26.61%	14.40%	37.29%	19.80%	18.25%	15.16%	4.37%	7.15%
Return on Equity Simple (ROE_SIMPLE)	23.07%	0.00%	48.71%	50.58%	44.89%	0.00%	23.38%	21.17%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	70	368	45	73	41	116	64	65	55	18	28
NOPAT Margin	6.93%	37.19%	4.87%	7.17%	4.16%	12.36%	6.87%	6.75%	5.96%	1.87%	2.89%
Net Nonoperating Expense Percent (NNEP)	2.45%	2.68%	-1.43%	2.53%	-0.58%	4.53%	1.50%	1.79%	1.60%	0.09%	1.92%
Return On Investment Capital (ROIC_SIMPLE)	-	23.94%	-	-	-	6.80%	3.52%	3.41%	2.75%	0.86%	1.34%
Cost of Revenue to Revenue	85.90%	86.87%	87.25%	85.50%	86.63%	85.73%	85.22%	85.45%	85.71%	87.13%	88.16%
SG&A Expenses to Revenue	5.13%	5.15%	5.57%	4.83%	5.20%	5.86%	5.03%	4.95%	5.78%	5.70%	5.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	5.13%	5.45%	5.79%	4.93%	8.06%	5.96%	5.03%	5.06%	6.11%	6.12%	7.55%
Earnings before Interest and Taxes (EBIT)	94	79	67	100	54	78	92	93	77	59	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	118	104	89	124	79	103	117	120	105	88	74
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.38	3.35	3.12	2.65	2.22	1.99	1.60	1.79	2.20	1.65	1.57
Price to Tangible Book Value (P/TBV)	6.07	3.66	3.40	2.86	2.56	2.28	1.81	2.12	2.60	1.93	1.82
Price to Revenue (P/Rev)	0.97	0.88	0.83	0.75	0.67	0.63	0.54	0.67	0.87	0.69	0.65
Price to Earnings (P/E)	25.28	7.15	6.62	5.40	5.08	8.94	7.08	8.74	10.58	12.91	14.81
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.23%	0.58%	1.02%
Earnings Yield	3.96%	13.99%	15.10%	18.51%	19.70%	11.18%	14.13%	11.44%	9.45%	7.75%	6.75%
Enterprise Value to Invested Capital (EV/IC)	5.48	3.47	3.18	2.70	2.32	2.16	1.69	1.92	2.50	1.82	1.66
Enterprise Value to Revenue (EV/Rev)	0.96	0.87	0.83	0.74	0.65	0.59	0.50	0.61	0.79	0.61	0.59
Enterprise Value to EBITDA (EV/EBITDA)	10.68	9.05	8.57	6.68	6.41	5.76	4.55	5.59	6.69	5.32	5.76
Enterprise Value to EBIT (EV/EBIT)	15.21	12.48	11.53	8.55	8.47	7.61	5.94	7.39	8.76	7.12	8.13
Enterprise Value to NOPAT (EV/NOPAT)	21.32	6.33	6.00	5.21	4.79	8.18	6.51	8.14	9.89	11.27	13.52
Enterprise Value to Operating Cash Flow (EV/OCF)	11.61	12.81	9.13	8.28	7.89	5.33	4.50	5.03	6.01	5.58	6.44
Enterprise Value to Free Cash Flow (EV/FCFF)	25.37	32.16	13.03	14.12	17.87	10.87	10.89	16.73	14.44	22.43	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.37	0.37	0.34	0.32	0.30	0.31	0.28	0.27	0.25	0.25
Long-Term Debt to Equity	0.51	0.35	0.36	0.33	0.30	0.29	0.29	0.27	0.26	0.24	0.24
Financial Leverage	-0.04	-0.19	-0.10	-0.09	-0.13	-0.16	-0.15	-0.15	-0.19	-0.21	-0.18
Leverage Ratio	3.23	2.73	2.65	2.56	2.53	2.30	2.27	2.20	2.17	2.07	2.11
Compound Leverage Factor	3.16	2.66	2.49	2.56	2.39	2.47	2.34	2.29	2.28	2.28	2.30
Debt to Total Capital	34.83%	26.98%	27.07%	25.50%	24.05%	23.26%	23.41%	21.94%	21.23%	19.89%	20.06%
Short-Term Debt to Total Capital	1.46%	1.17%	1.16%	1.12%	1.07%	1.05%	0.99%	0.94%	0.91%	0.87%	0.88%
Long-Term Debt to Total Capital	33.36%	25.81%	25.92%	24.38%	22.97%	22.20%	22.42%	21.00%	20.32%	19.02%	19.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	6.27%	5.53%	5.47%	5.29%	5.25%	4.75%	4.61%	3.96%	3.98%	4.03%	4.19%
Common Equity to Total Capital	58.91%	67.49%	67.46%	69.22%	70.70%	72.00%	71.98%	74.10%	74.79%	76.08%	75.75%
Debt to EBITDA	1.18	1.10	1.11	0.94	1.02	1.01	1.01	1.00	0.95	0.95	1.06
Net Debt to EBITDA	-0.26	-0.37	-0.31	-0.28	-0.45	-0.65	-0.61	-0.66	-0.83	-0.91	-0.78
Long-Term Debt to EBITDA	1.13	1.05	1.07	0.90	0.97	0.96	0.97	0.96	0.91	0.91	1.02
Debt to NOPAT	2.35	0.77	0.78	0.73	0.76	1.43	1.44	1.46	1.40	2.02	2.50
Net Debt to NOPAT	-0.51	-0.26	-0.22	-0.22	-0.33	-0.92	-0.88	-0.95	-1.23	-1.93	-1.83
Long-Term Debt to NOPAT	2.25	0.73	0.75	0.70	0.73	1.36	1.38	1.40	1.34	1.93	2.39
Altman Z-Score	4.82	4.31	4.22	4.28	3.88	3.92	3.71	3.67	3.87	3.52	3.41
Noncontrolling Interest Sharing Ratio	11.79%	9.70%	8.86%	8.00%	7.96%	6.82%	6.68%	5.97%	5.89%	5.35%	5.59%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.71	1.74	1.74	1.85	1.82	1.74	1.83	1.87	1.89	1.80	1.73
Quick Ratio	1.22	1.27	1.23	1.35	1.35	1.31	1.37	1.40	1.42	1.40	1.29
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	41	-66	-246	-279	-347	47	-55	-83	-40	-83	-176
Operating Cash Flow to CapEx	409.68%	227.91%	186.49%	183.87%	350.00%	495.12%	200.00%	0.00%	0.00%	262.22%	16.67%
Free Cash Flow to Firm to Interest Expense	10.31	-16.46	-61.40	-69.81	-86.80	15.69	-18.27	-20.64	-13.46	-27.76	-58.80
Operating Cash Flow to Interest Expense	31.75	24.50	17.25	14.25	24.50	67.67	23.33	23.75	42.33	39.33	2.00
Operating Cash Flow Less CapEx to Interest Expense	24.00	13.75	8.00	6.50	17.50	54.00	11.67	23.75	42.33	24.33	-10.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.72	1.53	1.52	1.56	1.49	1.38	1.35	1.29	1.22	1.19	1.18
Accounts Receivable Turnover	5.71	5.91	5.82	5.76	5.60	6.22	6.11	5.81	5.81	6.33	5.88
Inventory Turnover	10.80	10.73	9.78	10.66	10.61	11.48	10.17	10.80	10.14	11.72	10.48
Fixed Asset Turnover	11.30	0.00	10.05	10.09	9.61	0.00	8.82	8.48	8.11	0.00	7.75
Accounts Payable Turnover	5.74	5.74	5.85	6.24	5.94	6.32	5.91	6.04	5.95	6.19	5.61
Days Sales Outstanding (DSO)	63.97	61.76	62.71	63.42	65.14	58.72	59.70	62.84	62.78	57.69	62.05
Days Inventory Outstanding (DIO)	33.81	34.00	37.31	34.23	34.40	31.79	35.87	33.79	35.99	31.13	34.82
Days Payable Outstanding (DPO)	63.62	63.59	62.41	58.46	61.48	57.79	61.73	60.46	61.31	58.93	65.02
Cash Conversion Cycle (CCC)	34.17	32.17	37.61	39.19	38.06	32.73	33.84	36.17	37.46	29.88	31.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	708	985	1,018	1,075	1,096	1,054	1,137	1,223	1,191	1,259	1,341
Invested Capital Turnover	5.81	5.15	4.49	4.39	4.34	3.79	3.59	3.33	3.29	3.12	3.06
Increase / (Decrease) in Invested Capital	29	434	291	352	388	69	119	148	95	101	204
Enterprise Value (EV)	3,877	3,421	3,240	2,907	2,540	2,275	1,926	2,344	2,977	2,286	2,229
Market Capitalization	3,893	3,474	3,271	2,945	2,629	2,450	2,102	2,543	3,269	2,595	2,444
Book Value per Share	$25.67	$37.32	$38.01	$40.33	$42.92	$44.50	$48.49	$52.17	$54.37	$58.47	$58.02
Tangible Book Value per Share	$22.73	$34.09	$34.86	$37.29	$37.24	$39.00	$42.84	$43.95	$46.16	$50.19	$49.96
Total Capital	1,229	1,538	1,555	1,608	1,676	1,707	1,824	1,919	1,983	2,061	2,054
Total Debt	428	415	421	410	403	397	427	421	421	410	412
Total Long-Term Debt	410	397	403	392	385	379	409	403	403	392	394
Net Debt	-93	-138	-116	-123	-177	-256	-260	-275	-371	-392	-301
Capital Expenditures (CapEx)	31	43	37	31	28	41	35	0.00	0.00	45	36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	207	185	203	264	230	72	130	149	90	38	104
Debt-free Net Working Capital (DFNWC)	692	703	710	772	783	698	788	820	855	811	786
Net Working Capital (NWC)	674	685	692	754	765	680	770	802	837	793	768
Net Nonoperating Expense (NNE)	-0.77	-4.84	1.40	-2.25	0.78	-8.93	-2.82	-3.56	-4.37	-0.28	-5.39
Net Nonoperating Obligations (NNO)	-93	-138	-116	-123	-177	-256	-260	-275	-371	-392	-301
Total Depreciation and Amortization (D&A)	24	25	22	24	25	25	25	27	28	29	29
Debt-free, Cash-free Net Working Capital to Revenue	5.14%	4.68%	5.18%	6.68%	5.87%	1.86%	3.36%	3.90%	2.39%	1.01%	2.75%
Debt-free Net Working Capital to Revenue	17.18%	17.78%	18.11%	19.54%	19.99%	18.05%	20.38%	21.45%	22.75%	21.52%	20.75%
Net Working Capital to Revenue	16.73%	17.32%	17.65%	19.08%	19.53%	17.59%	19.91%	20.98%	22.27%	21.05%	20.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.35	$13.03	$1.52	$2.57	$1.41	$4.43	$2.39	$2.38	$2.09	$0.53	$1.16
Adjusted Weighted Average Basic Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M
Adjusted Diluted Earnings per Share	$2.32	$12.85	$1.50	$2.54	$1.40	$4.38	$2.36	$2.36	$2.04	$0.52	$1.14
Adjusted Weighted Average Diluted Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.81M	27.49M	27.60M	27.61M	27.62M	27.08M	27.26M	27.28M	27.29M	26.82M	26.69M
Normalized Net Operating Profit after Tax (NOPAT)	70	55	47	74	63	55	64	66	57	48	40
Normalized NOPAT Margin	6.93%	5.59%	5.02%	7.25%	6.40%	5.89%	6.87%	6.83%	6.20%	5.02%	4.17%
Pre Tax Income Margin	9.07%	7.78%	6.75%	9.86%	5.20%	8.95%	10.17%	10.01%	8.83%	6.86%	5.14%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.50	19.75	16.75	25.00	13.50	26.00	30.67	23.25	25.67	19.67	15.00
NOPAT to Interest Expense	17.56	92.04	11.35	18.19	10.20	38.69	21.39	16.36	18.21	5.91	9.20
EBIT Less CapEx to Interest Expense	15.75	9.00	7.50	17.25	6.50	12.33	19.00	23.25	25.67	4.67	3.00
NOPAT Less CapEx to Interest Expense	9.81	81.29	2.10	10.44	3.20	25.02	9.73	16.36	18.21	-9.09	-2.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	17.37%	5.74%	4.11%	2.49%	0.38%	4.23%	5.21%	9.97%	12.50%	16.90%	23.73%
Augmented Payout Ratio	62.87%	26.73%	28.77%	19.54%	9.77%	26.41%	21.50%	26.58%	28.13%	43.66%	68.93%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, four-year trend view of Visteon (VC) based on quarterly income statements, balance sheets, and cash flow statements. It highlights key cash flow, profitability, liquidity, and capital allocation trends that could be relevant to a retail investor assessing the stock.

Solid operating cash flow: Visteon has generated positive cash from operations in multiple quarters over the four-year window (examples: about $203M in 2024 Q4 and typically $70–$127M in 2025 quarters), indicating strong cash generation from core operations.
Meaningful discretionary free cash flow potential: After accounting for capex (roughly $28M–$45M per quarter in several periods) and modest investing activity, quarterly free cash flow remains positive in several recent quarters, supporting debt service and buybacks.
Healthy liquidity position: Cash and equivalents have generally ranged from roughly $0.55B to $0.76B across recent quarters, supporting short-term liquidity needs and flexibility.
Manageable leverage with stable interest expense: Long-term debt has been in the low-to-mid hundreds of millions (roughly $288M–$327M over the period), with interest expense typically around $3–4M per quarter, suggesting manageable leverage and predictable financing costs.
Capital return activity: The company executed sizable share repurchases in 2025 (e.g., about $50M in Q2 and again in Q4), signaling an active capital-return program that can be appealing to equity holders.
Revenue is broadly range-bound: Across 2022–2025, operating revenue generally sits in the $0.93B–$1.06B band, indicating stability but no clear, sustained growth trajectory over the period.
Gross margin relatively stable: Historical gross margins have traded in the mid-teens (roughly 12%–14%), with modest quarter-to-quarter variation, indicating steady core profitability without clear swing-margin expansion.
Net income and earnings per share show quarterly volatility: Net income to common and EPS have fluctuated notably, with 2025 Q4 showing a marked drop (e.g., net income to common around $14M and EPS about $0.53) after stronger recent quarters, pointing to near-term earnings weakness.
Working-capital intensity and current liabilities: Accounts payable and other current liabilities are sizable (e.g., current liabilities frequently near or above $0.9B), which can pressure liquidity management and indicate a higher working-capital needs profile.

Overall, VC demonstrates solid operating cash generation and a constructive liquidity/financing position, with active capital returns. However, near-term earnings can be volatile, and working-capital dynamics warrant watching as margins and quarterly profitability fluctuate. If you’d like, I can distill these findings into a quick, year-by-year chart summary or provide a more granular, year-by-year KPI table.

05/05/26 06:39 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Visteon's Financials

When does Visteon's financial year end?

According to the most recent income statement we have on file, Visteon's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Visteon's net income changed over the last 10 years?

Visteon's net income appears to be on a downward trend, with a most recent value of $213 million in 2025, falling from $2.33 billion in 2015. The previous period was $306 million in 2024. Check out Visteon's forecast to explore projected trends and price targets.

What is Visteon's operating income?

Visteon's total operating income in 2025 was $322 million, based on the following breakdown:

Total Gross Profit: $532 million
Total Operating Expenses: $210 million

How has Visteon's revenue changed over the last 10 years?

Over the last 10 years, Visteon's total revenue changed from $3.25 billion in 2015 to $3.77 billion in 2025, a change of 16.1%.

How much debt does Visteon have?

Visteon's total liabilities were at $1.74 billion at the end of 2025, a 11.8% increase from 2024, and a 50.2% decrease since 2015.

How much cash does Visteon have?

In the past 10 years, Visteon's cash and equivalents has ranged from $452 million in 2021 to $2.73 billion in 2015, and is currently $771 million as of their latest financial filing in 2025.

How has Visteon's book value per share changed over the last 10 years?

Over the last 10 years, Visteon's book value per share changed from 25.89 in 2015 to 58.47 in 2025, a change of 125.8%.

Related Companies

Financial statements for NASDAQ:VC last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Visteon (VC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Visteon's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Visteon (VC) Financials

Annual Income Statements for Visteon

Quarterly Income Statements for Visteon

Annual Cash Flow Statements for Visteon

Quarterly Cash Flow Statements for Visteon

Annual Balance Sheets for Visteon

Quarterly Balance Sheets for Visteon

Annual Metrics And Ratios for Visteon

Quarterly Metrics And Ratios for Visteon

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Visteon's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools